维普期刊资源整合服务平台（V6.5）

99篇 您的检索式：作者名="van TINTEREN H"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	FDG-PET/CT response evaluation during EGFR-TKI treatment in patients with NSCLC显示文摘Over recent years,[18F]-fluorodeoxyglucose positron emission tomography acquired together with low dose computed tomography(FDG-PET/CT)has proven its role as a staging modality in patients with non-small cell lung cancer(NSCLC).The purpose of this review was to present the evidence to use FDG-PET/CT for response evaluation in patients with NSCLC,treated with epidermal growth factor receptor(EGFR)-tyrosine kinase inhibitors(TKI).All published articles from 1November 2003 to 1 November 2013 reporting on 18FFDG-PET response evaluation during EGFR-TKI treatment in patients with NSCLC were collected.In total 7studies,including data of 210 patients were eligible for analyses.Our report shows that FDG-PET/CT responseduring EGFR-TKI therapy has potential in targeted treatment for NSCLC.FDG-PET/CT response is associated with clinical and radiologic response and with survival.Furthermore FDG-PET/CT response monitoring can be performed as early as 1-2 wk after initiation of EGFR-TKI treatment.Patients with substantial decrease of metabolic activity during EGFR-TKI treatment will probably benefit from continued treatment.If metabolic response does not occur within the first weeks of EGFR-TKI treatment,patients may be spared(further)unnecessary toxicity of ineffective treatment.Refining FDG-PET response criteria may help the clinician to decide on continuation or discontinuation of targeted treatment.	Matthijs H van Gool Tjeerd S Aukema Koen J Hartemink Renato A Valdés Olmos Houke M Klomp Harm van Tinteren	2014	World Journal of Radiology2014，6，7：	8
2	Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial 显示文摘	van Tinteren H Hoekstra OS Smit EF	2002	Lancet2002，359，：	1
3	Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase Ⅲ randomised cairo study显示文摘	Koopman M Venderbosch S van Tinteren H	2009	Eur J Cancer2009，45，11：	1
4	P27Kip1 expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-up显示文摘	Barbareschi M Van Tinteren H Mauri FA	2000	Int J Cancer2000，89，：	1
5	Toxicity of cytore- ductive surgery and hyperthermic in- traperitoneal chemotherapy 显示文摘	Verwaal V J van Tinteren H Ruth S V Zoetmulder F A	2004	J Surg Oncol2004，85，2：	1
6	Malignant rhabdoid tumours of the kidney (MRTKs) , registered on recent SIOP protocols from 1993 to 2005: areport of the SlOP renal tumour study group 显示文摘	van den Heuvel-Eibrink MM van Tinteren H Rehorst H	2011	Pediatr Blood Cancer2011，56，：	1
7	Malignant rhabdoid turnouts of the kidney (MRTKs),registered on recent SIOP protocols from 1993 to 2005:a report of the SIOP renal tumour study group显示文摘	van den Heuvel-Eibrink MM van Tinteren H Rehorst H	2011	Pediatr Blood Cancer2011，56，5：	1
8	Sleep endoscopy versus modified Mallampati score in sleep apnea and snoring显示文摘	den Herder C van Tinteren H de Vries N	2005	Laryngoscope2005，115，4：	1
9	Effectiveness of position emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer显示文摘	Van tinteren H Hoekstra OS Smitt EF	2002	Lancet2002，359，：	1
10	Amplification of genes within the chromosome 1 l q13 region is indicative of poor prognosis inpatients with operable breast cancer显示文摘	SCHUURING E VERHOEVEN E van TINTEREN H	1992	Cancer Res1992，52，10：	1
11	Long-term impact of the 70-gene signature on breast cancer outcome显示文摘	Drukker CA van Tinteren H Schmidt MK	2014	Breast Cancer Res Treat2014，143，3：	1
12	Use of thoracic radiotherapy for extensive stage small-cell lung canc- er: a phase 3 randomised controlled trial 显示文摘	SLOTMAN B J Van TINTEREN H PRAAG J O	2015	Lancet2015，385，9962：	1
13	Postoperative serum proteomie profiles May predict recurrence-free sur- vival in high-risk primary breast Cancer显示文摘	Gast MC Zapatka M van Tinteren H	2011	J Cancer Res Clin Oncol2011，137，12：	1
14	Sleep endoscopy versus modified Mallampati score in sleep apnea and snoring显示文摘	den Herder C van Tinteren H de Vries N	2005	Laryngoscope2005，115，4：	1
15	Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase Ⅲ randomised CAIRO study 显示文摘	KOOPMAN M VENDERBOSCH S VAN TINTEREN H	2009	Eur J Cancer2009，45，11：	1
16	Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3) : a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group 显示文摘	SIMKENS L H VAN TINTEREN H MAY A	2015	Lancet2015，385，9980：	1
17	Active-specific immunotherapy for stage Ⅱ and stage Ⅲ human colon cancer:A randomised trial显示文摘	Vermorken JB Claessen AM van Tinteren H	1999	Lancet1999，353，9150：	1
18	Predicting early failure after adjuvant chemotherapy in high-risk breast cancer patients with extensive lymph node involvement显示文摘	Faneyte IF Peterse JL Van Tinteren H	2004	Clin Cancer Res2004，10，13：	1
19	Reduction of postoperative chemotherapy in children with stage Ⅰ intermediate-risk and anaplastic Wilms'tumour ( SIOP 93-01 trial ) : a randomized controlled trial显示文摘	de Kraker J Graf N van Tinteren H	2004	Lancet2004，364，9441：	1
20	Active-specific immunotherapy for stage Ⅱ and stage Ⅲ human colon cancer:a randomised trial显示文摘	Vermorken JB Claessen AM van Tinteren H	1999	Lancet1999，353，9150：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示